Evaluation of The Hypoglycemic Potential of The Ethanolic Bulb Extract of Allium Chinense G. Don (Sibujing) On High-Glucose Induced Hyperglycemic Swiss Albino Mice
Evaluation of The Hypoglycemic Potential of The Ethanolic Bulb Extract of Allium Chinense G. Don (Sibujing) On High-Glucose Induced Hyperglycemic Swiss Albino Mice
Abstract: This study investigated the hypoglycemic potential of the ethanolic bulb extract of Allium chinense G. Don,
commonly known as Sibujing, a spice used in Maranao cuisine. Given the rising global prevalence of hyperglycemia and
diabetes mellitus, with 14,416 deaths due to diabetes mellitus in the Philippines alone in 2023, effective treatments are crucial.
Swiss albino mice were induced with hyperglycemia via a high-glucose diet to evaluate the extract's potential in managing
elevated glucose levels. Phytochemical screening of the crude extract revealed the presence of flavonoids, alkaloids, phenols,
saponins, steroids, and terpenoids, with the absence of tannins. Quantitative analysis showed a total phenolic content (TPC)
of 13.2±1.0 mg gallic acid per gram extract and a total flavonoid content (TFC) of 9.8±0.1 mcg quercetin per gram extract.
Acute oral toxicity testing indicated an LD50 >2000 mg/kg body weight, with no observed deaths or toxic symptoms.
However, statistical analysis using One-Way ANOVA and post-hoc tests demonstrated that administration of the crude
extract at varying doses (50, 300, 2000 mg/kg) did not result in a significant reduction in blood glucose levels compared to
both the negative control (normal saline solution) and the positive control (metformin, 50 mg/kg). All pairwise comparisons
yielded non-significant results (p>0.05), suggesting that under the conditions of this study, the ethanolic bulb extract of A.
chinense did not exhibit significant hypoglycemic activity comparable to metformin.
Keywords: Hyperglycemia, High Glucose, Crude Extract, Allium Chinense G. Don, Swiss Albino Mice.
How to Cite: Kline Melody P. Nietes; Raha D, Abdulrauf; Michaela Krystelle G. Ong; Christian Caleb G. Sacedon; Junin Gay L.
Garay; Roselle T. Remulta; Rezeile Dale V. Pancho; (2025) Evaluation of the Hypoglycemic Potential of the Ethanolic Bulb
Extract of Allium Chinense G. Don (Sibujing) on High-Glucose Induced Hyperglycemic Swiss Albino Mice. International
Journal of Innovative Science and Research Technology, 10(7), 1254-1263. https://doi.org/10.38124/ijisrt/25jul885
The average percentage yield based on the three replicants of 20 grams of dried powdered bulbs of A. chinense G. Don soaked
in 200 ml of ethanol is 66.67%. Table 1 shows the individual yield obtained from each replicant.
Table 1 The percentage yield of the crude ethanolic bulb extract of A. chinense G. Don
Replicant Weight of dried leaves (g) Weight of crude extract (g) Percentage yield (%)
1 20 3.3 66
2 20 3.3 66
3 20 3.4 68
Mean Value 66.67
Both replicants 1 and 2 yielded 66% while the third replicant yielded 68% in every 20 grams of the crude extract hence, the
mean value is 66.67%.
Phytochemical Analysis
The phytochemical screening for secondary metabolites of the ethanolic bulb extract of A. chinense G. Don followed the
procedures and tests found in chapter 3 to determine the presence of phytochemical compounds such as flavonoids, alkaloids,
saponins, tannins, and steroids (Tinoy et al. 2024). A quantitative analysis of the Total Phenolic Content (TPC) and Total Flavonoid
Content (TFC) of the crude extract was also performed to quantify the number of flavonoids and phenols present in the extract
which are some of the phytochemicals responsible for the hypoglycemic activity of the Allium family (Nakamura et al.) (Hill et al.).
Table 2 Results for Phytochemical Tests for Secondary Metabolites of A. chinense G. Don
The phytochemical analysis of the ethanolic crude was performed to determine the concentrations present in the
extract of A. chinense G. Don as shown in Table 2 shows a ethanolic bulb extract that may contribute to its hypoglycemic
positive result for alkaloids, flavonoids, phenols, saponins, activity (Sabiu et al. 2019) (Nakamura et al. 2021)
steroids, terpenoids, and a negative result for tannins. (Chakraborty et al. 2022) (Hill and Foroozand et al. 2023).
Table 3 shows the results for the quantitative analysis of A.
Additionally, a quantitative analysis of the Total chinense G. Don.
Phenolic Content (TPC) and Total Flavonoid Content (TFC)
The TFC and TPC of the crude extract of A. chinense body weight) of the ethanolic bulb extract of A. chinense G.
G. Don showed that the TFC is 9.8±0.1 mcg Quercetin per Don. The low dose was 50 mg/kg for the low dose, 300 mg/kg
gram extract and the TPC is 13.2±1.0 mg gallic acid per gram for the mid dose, and 2000 mg/kg for the high dose. The
extract indicating that there is a sufficient amount that can intestines, spleen, kidney, and liver were also in good
potentially cause a hypoglycemic activity. condition. There were no lesions, perforations, or any
deformities of any kind nor any changes to the texture of the
Acute Toxicity Tests internal organs of the mice. Therefore, the LD50 is estimated
No deaths were recorded after 24 hours of at LD50 >2000 mg/kg body weight in mice.
administration of the various doses (3, 50, 300, 2000 ml/kg
The acute toxicity test indicated that the ethanolic bulb Summary of Findings
extract of A. chinense G. Don is safe up to a dose of 2000 The ethanolic bulb extract of A. chinense G. Don was
mg/kg body weight, with no observed mortality or adverse successfully prepared, yielding an average of 66.67%.
effects. This suggests a wide therapeutic window if any Phytochemical screening confirmed the presence of
efficacy were to be found. flavonoids, alkaloids, phenols, saponins, steroids, and
terpenoids, but not tannins. Quantitative analysis revealed
However, the core finding of the study, as revealed by TPC of 13.2±1.0 mg GAE/g extract and TFC of 9.8±0.1 mcg
the repeated measures ANOVA, is the lack of a statistically QE/g extract. The acute toxicity test indicated an LD50
significant difference in blood glucose reduction across the >2000 mg/kg body weight, confirming the extract's safety at
various doses of A. chinense extract, the negative control, and the tested doses. However, statistical analysis using repeated
the metformin-positive control. While blood glucose levels measures ANOVA showed no significant differences in
did change significantly over time in all groups (likely due to blood glucose levels among the various A. chinense extract
the acute glucose challenge and subsequent physiological doses, the negative control, and the metformin-positive
regulation), the extract did not demonstrate a distinct glucose- control groups. The interaction between time and treatment
lowering pattern or magnitude comparable to metformin, nor was also not significant, indicating similar patterns of glucose
did it significantly differ from the untreated hyperglycemic change across all groups.
control. This suggests that the extract, at the tested doses and
under the specific experimental conditions (high-glucose Conclusion
induction, Swiss albino mice model, and duration of Based on the current findings, the ethanolic bulb extract
observation), did not exert a notable antidiabetic effect. of Allium chinense G. Don did not exhibit a statistically
significant hypoglycemic effect on high-glucose induced
This outcome contrasts with some related studies on hyperglycemic Swiss albino mice under the conditions of this
other Allium species, such as A. hookeri, A. sativum, and A. study. The presence of secondary metabolites such as
cepa, which have shown promising antidiabetic effects in flavonoids, saponins, alkaloids, phenols, terpenoids, and
animal models (Choi et al., 2022; Jalal et al., 2007; Xie et al., steroids, while confirmed, did not translate into a measurable
2023). The discrepancy could be attributed to several factors: reduction in blood glucose levels comparable to the standard
antidiabetic drug metformin. Therefore, the null hypothesis,
Species-specific differences: While belonging to the same stating that the ethanolic bulb extract of A. chinense G. Don
genus, the phytochemical profiles and biological activities would have no significant effect on blood glucose levels
of A. chinense may vary significantly from other Allium compared to the control group treated with metformin, is
species. accepted.
Extraction method: Although ethanol is a common
solvent, different extraction methods or solvents might Recommendations
yield different concentrations or types of active Based on these findings, the researchers recommend the
compounds. following for future studies:
Dosage and duration: The tested doses, while covering a
wide range, might not have been optimal, or the 8-week Alternative Diabetic Models: Utilize established diabetic
treatment period might have been insufficient to observe mouse models such as Non-Obese Diabetic (NOD) mice,
a significant long-term effect or a more pronounced Akita mice, or db/db and ob/ob mice, which may more
reduction in chronic hyperglycemia. closely mimic human T2DM pathophysiology and offer
Animal model: While Swiss albino mice are common, different sensitivities to potential therapeutic agents.
other diabetic mouse models (e.g., NOD, Akita, db/db, Chemical Induction Methods: Consider chemical
ob/ob mice) or different induction methods (e.g., alloxan induction of diabetes using alloxan or streptozotocin
or streptozotocin) might respond differently to the extract. (STZ) via the intraperitoneal route, which can provide a
The high-glucose induction method might have created a more consistent and well-characterized diabetic state.
hyperglycemia model that was not sufficiently responsive Alternative Positive Controls: Explore therapeutic
to the extract's potential subtle effects. alternatives for positive controls, such as Linaligliptin or
Metabolic complexity: T2DM involves complex Glibenclamide, which represent different classes of
pathophysiological mechanisms, including insulin antidiabetic drugs and may provide a broader comparative
resistance and β-cell dysfunction (Galicia-Garcia et al., context.
2020). The extract might not effectively target these Further Formulation Studies: Given the presence of
specific pathways in the induced model. saponins, investigate the formulation of a soap containing